Electronucleics Inc.
Placentia, CA
- UEI
- F2C3LMC4JV17
- CAGE
- 7YZH3
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2302 Navigation Cir, Placentia, CA 92870, USA
- Website
- electronucleics.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Electronucleics Inc. is a company that specializes in rapid, low-cost pathogen detection at the point of care. Their innovative nucleic acid detection technology allows for quick and accurate diagnosis in just 5 minutes. The portable device is designed to facilitate prompt, well-informed therapies and counseling and to avoid potentially harmful actions including the inappropriate prescription of antibiotics. Electronucleics is registered as a self-certified small disadvantaged business and for-profit organization.
Electronucleics Inc. has received multiple federal grant awards to develop rapid point-of-care tests for detecting various infectious diseases. In 2023, they were awarded a $551,520 cooperative agreement from the Centers for Disease Control and Prevention (CDC) to develop a rapid point-of-care test for human papillomavirus (HPV) detection, funded through the Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases program. Additionally, in 2023 and 2021, Electronucleics received project grants totaling $725,491 from the National Institute of Allergy and Infectious Diseases (NIAID) to demonstrate the feasibility of their patented detector technology for rapid point-of-care detection of Trichomonas vaginalis in vaginal swab samples and Chlamydia trachomatis in urine samples. These awards aim to leverage Electronucleics' novel electromechanical signal transduction mechanism enabling low-cost, optics-free, and amplification-free nucleic acid detection at ultralow concentrations.
Quick answers
Is Electronucleics Inc. registered in SAM.gov?
Yes. Electronucleics Inc.'s SAM.gov registration is active through August 22, 2027.
What is Electronucleics Inc.'s most recent federal award?
Electronucleics Inc.'s most recent federal grant award is Sbir PA22-176 - rapid point-of-care detection of human papillomavirus (R43IP001231), from Office of Financial Resources (CDC), on September 30, 2023.
On GovTribe
See Electronucleics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors